NASDAQ
Anebulo Pharmaceuticals, Inc. (ANEB) has a eps (diluted) of $-0.25 as of Monday, June 30, 2025. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.